Point-of-care diagnostics: testing at the bedside

What point-of-care testing means

Point-of-care testing, often shortened to POCT, simply means carrying out a diagnostic test near the patient and getting a result quickly, rather than sending a sample away to a central laboratory. The test might be done at a hospital bedside, in a GP clinic, in a pharmacy, in an ambulance, or by patients themselves at home. The devices are designed to be small, robust, and easy to use, often needing only a drop of blood, a swab, or a urine sample. The defining feature is speed: results usually arrive within minutes. This allows a clinician to make a decision — start a treatment, send someone home, or arrange urgent care — while the patient is still in front of them.

How the technology works

Point-of-care devices use clever miniaturised versions of laboratory methods. Some rely on lateral flow technology — the same principle as a pregnancy test — where a sample travels along a strip and produces a coloured line if a particular substance is present. Others use small electronic biosensors, such as the glucose meters that measure blood sugar through a chemical reaction on a test strip. More sophisticated cartridge-based machines can run several blood tests at once, and some now use molecular methods to detect the genetic material of viruses and bacteria in under an hour. Increasingly, results are sent automatically to a patient's electronic record. The engineering challenge is packing laboratory-grade chemistry into a device simple enough to use reliably outside a lab.

Where it makes a difference

Point-of-care testing is most valuable when a fast result changes what happens next. In emergencies, a bedside test for troponin can help assess a possible heart attack, and blood gas analysers guide the care of critically ill patients within minutes. In GP surgeries, C-reactive protein tests can help decide whether an infection is likely bacterial, supporting better antibiotic decisions and reducing unnecessary prescriptions. Rapid tests for infections such as COVID-19, flu, and strep throat allow quick isolation or treatment. For long-term conditions, home monitoring — glucose meters for diabetes, and INR testing for people on certain blood thinners — lets patients manage their own health with fewer clinic visits. In each case, the benefit is timely action rather than waiting.

Benefits and limitations

The advantages of point-of-care testing are clear: faster decisions, less waiting, fewer repeat visits, and care delivered closer to home. This can ease pressure on hospitals and empower patients to take part in their own care. But there are trade-offs. Point-of-care tests are sometimes less precise than full laboratory analysers, and results can be affected by how the sample is taken or how the device is used, so good training and quality checks are essential. They are usually more expensive per test than centralised lab testing. A false result — either wrongly reassuring or wrongly alarming — can cause harm if acted on blindly. For these reasons, point-of-care results are often confirmed by a laboratory when the stakes are high or the finding is unexpected.

The future of testing at the bedside

Point-of-care diagnostics are advancing quickly. Smartphone-connected devices can now read tests, store results, and share them securely with clinicians, supporting remote and virtual care. Wearable sensors are beginning to track markers continuously rather than at a single moment, and research is pushing towards tiny "lab-on-a-chip" devices that run many tests from a single drop of blood. Artificial intelligence is being explored to interpret results and flag concerning patterns. As accuracy improves and costs fall, more testing is likely to move out of laboratories and into clinics, pharmacies, and homes. The goal is not to replace laboratories, which remain vital for complex and confirmatory testing, but to complement them — putting the right test in the right place at the right time.